Swiss National Bank Macrogenics Inc Transaction History

Swiss National Bank

$150 Billion
Q3 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 07, 2024	BUY	$9.77 - $21.47 $896,886 - $1.97 Million	91,800 New	91,800 $1.35 Million
Q2 2022 Aug 09, 2022	SELL	$2.25 - $9.99 $49,275 - $218,781	-21,900 Reduced 18.91%	93,900 $277,000
Q1 2022 May 09, 2022	BUY	$8.12 - $16.9 $66,584 - $138,580	8,200 Added 7.62%	115,800 $1.02 Million
Q4 2021 Feb 08, 2022	BUY	$15.91 - $21.88 $23,865 - $32,820	1,500 Added 1.41%	107,600 $1.73 Million
Q3 2021 Nov 08, 2021	BUY	$19.74 - $28.7 $136,206 - $198,030	6,900 Added 6.96%	106,100 $2.22 Million
Q2 2021 Aug 06, 2021	SELL	$20.49 - $35.63 $467,171 - $812,364	-22,800 Reduced 18.69%	99,200 $2.67 Million
Q1 2021 May 07, 2021	BUY	$18.99 - $33.2 $110,141 - $192,560	5,800 Added 4.99%	122,000 $3.89 Million
Q4 2020 Feb 05, 2021	BUY	$19.41 - $26.0 $201,864 - $270,400	10,400 Added 9.83%	116,200 $2.66 Million
Q3 2020 Nov 09, 2020	BUY	$24.69 - $31.6 $46,911 - $60,040	1,900 Added 1.83%	105,800 $2.67 Million
Q2 2020 Aug 05, 2020	BUY	$5.2 - $29.12 $71,760 - $401,856	13,800 Added 15.32%	103,900 $2.9 Million
Q1 2020 May 08, 2020	BUY	$4.28 - $12.11 $5,136 - $14,532	1,200 Added 1.35%	90,100 $524,000
Q4 2019 Feb 06, 2020	BUY	$7.95 - $12.27 $21,465 - $33,129	2,700 Added 3.13%	88,900 $967,000
Q2 2019 Aug 02, 2019	BUY	$14.51 - $19.71 $50,785 - $68,985	3,500 Added 4.23%	86,200 $1.46 Million
Q1 2019 May 10, 2019	BUY	$11.11 - $25.6 $172,205 - $396,800	15,500 Added 23.07%	82,700 $1.49 Million
Q4 2018 Feb 13, 2019	BUY	$11.75 - $21.42 $29,375 - $53,550	2,500 Added 3.86%	67,200 $853,000
Q1 2018 May 04, 2018	BUY	$18.89 - $32.46 $96,339 - $165,546	5,100 Added 8.56%	64,700 $1.63 Million
Q4 2017 Feb 07, 2018	BUY	$16.19 - $20.3 $71,236 - $89,320	4,400 Added 7.97%	59,600 $1.13 Million
Q3 2017 Nov 03, 2017	BUY	$15.52 - $18.94 $856,704 - $1.05 Million	55,200	55,200 $1.02 Million

Others Institutions Holding MGNX

# of Institutions

132

Shares Held

55.4M

Call Options Held

215K

Put Options Held

238K

Bellevue Group Ag Kuesnacht, V8

9.93M
Shares

$32.4 Million
0.55% of portfolio
Armistice Capital, LLC New York, NY

6.26M
Shares

$20.4 Million
0.34% of portfolio
Black Rock Inc. New York, NY

5.4M
Shares

$17.6 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

4.36M
Shares

$14.2 Million
0.0% of portfolio
Israel Englander Millennium Management LLC | New York, Ny

3.54M
Shares

$11.5 Million
0.01% of portfolio

View Full List

About MACROGENICS INC

Ticker MGNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 61,458,800
Market Cap $200M
Description
MacroGenics, Inc., a biopharmaceutical company, develops and commercializes antibody-based therapeutics to treat cancer in the United States. Its approved product is MARGENZA (margetuximab-cmkb), a human epidermal growth factor receptor 2 (HER2) receptor antagonist indicated, in combination with chemotherapy, for the treatment of adult patients ...

More about MGNX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Swiss National Bank, based on Form 13F filings with the SEC.

News

Stay updated on Swiss National Bank with notifications on news.

Account